Half-year results presentation (SFAF) | Paris | Innate Pharma

SFAFF meeting

Date

Wed, 09/17/2014 - 09:21

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers